Document Detail


Mood changes during captopril therapy for hypertension. A double-blind pilot study.
MedLine Citation:
PMID:  6354937     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A small double-blind pilot study was carried out to assess whether captopril treatment in hypertension has a euphoriant effect. Eight patients were maintained on constant therapy of atenolol and bendrofluazide for at least 4 weeks before and throughout the study. Captopril 25 mg three times daily or matching placebo was administered double-blind for 6 weeks, with crossover to placebo or captopril from Weeks 7 to 12. Psychiatric assessment was made at Weeks 3, 6, 9, and 12. During the captopril phase, blood pressure was reduced, plasma angiotensin II lowered, and plasma renin raised. Mood was slightly, but significantly, lower during captopril administration; thus, there was no evidence of an euphoriant effect of captopril. This pilot trial also indicates the feasibility of the approach, and such studies of hypertensives under therapy should be usefully extended and refined.
Authors:
J S Callender; G P Hodsman; M J Hutcheson; A F Lever; J I Robertson
Related Documents :
3038407 - Possible role of vascular angiotensin converting enzyme in the genesis of hypertension.
22417477 - Sex differences in primary hypertension.
11300367 - Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hy...
15215177 - Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase ...
499317 - Prazosin, pharmacokinetics and concentration effect.
8063667 - Frequency dependence of pulmonary and chest wall mechanics in young and adult cats.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Hypertension     Volume:  5     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:    1983 Sep-Oct
Date Detail:
Created Date:  1983-12-17     Completed Date:  1983-12-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  III90-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Captopril / therapeutic use*
Double-Blind Method
Drug Evaluation
Euphoria
Female
Humans
Hypertension / drug therapy*,  psychology
Male
Middle Aged
Placebos
Proline / analogs & derivatives*
Questionnaires
Chemical
Reg. No./Substance:
0/Placebos; 147-85-3/Proline; 62571-86-2/Captopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renin system activity as a determinant of response to treatment in hypertension and heart failure.
Next Document:  Significance of urinary metallothionein in workers exposed to cadmium.